CALLIDUS BIOMOLECULES LIMITED

Company number SC586605 · Monitor this company

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£8,677

Balance sheet as at 2024-01-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2018-01-24
Employees: 1 (2025 accounts)
Registered office: Ormsary Cottage, Oyne, Insch, Scotland, AB52 6QT
Postcode: AB52 6QT
Capital: 1,000 GBP
Accounts category: Micro

Accounts

Last made up to: 2025-01-31
Next due by: 2026-10-31
Financial year end: 31 January

Confirmation statement

Last statement dated: 2026-04-15
Next due by: 2027-04-29

View filing history →

Nature of business (SIC)

72110 Research and experimental development on biotechnology

Officers 2 current

Daniel, Dr OZANNE Director

Appointed 2018-01-24

DR DANIEL OZANNE Director

SCIENTIST Appointed 2018-01-24

View all officers and resignations →

Competitors Aberdeen

1. NODTHERA LIMITED

£70,903,296
2. BEAD BIOPHARMA LIMITED

£2,514,108
3. SCOTIA BIOLOGICS LIMITED

£887,776
4. TAURX THERAPEUTICS MANAGEMENT LTD.

£205,698
5. CYCLOGENIX LIMITED

£83,637

This company ranks 8 among research and experimental development on biotechnology in Aberdeen.

Full league table →

The class of 2018

36%

of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →